Correlation Between Equillium and Cytek Biosciences
Can any of the company-specific risk be diversified away by investing in both Equillium and Cytek Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Equillium and Cytek Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Equillium and Cytek Biosciences, you can compare the effects of market volatilities on Equillium and Cytek Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Equillium with a short position of Cytek Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Equillium and Cytek Biosciences.
Diversification Opportunities for Equillium and Cytek Biosciences
-0.4 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Equillium and Cytek is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Equillium and Cytek Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cytek Biosciences and Equillium is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Equillium are associated (or correlated) with Cytek Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cytek Biosciences has no effect on the direction of Equillium i.e., Equillium and Cytek Biosciences go up and down completely randomly.
Pair Corralation between Equillium and Cytek Biosciences
Allowing for the 90-day total investment horizon Equillium is expected to generate 2.8 times more return on investment than Cytek Biosciences. However, Equillium is 2.8 times more volatile than Cytek Biosciences. It trades about 0.11 of its potential returns per unit of risk. Cytek Biosciences is currently generating about -0.32 per unit of risk. If you would invest 66.00 in Equillium on December 1, 2024 and sell it today you would earn a total of 10.00 from holding Equillium or generate 15.15% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Equillium vs. Cytek Biosciences
Performance |
| Timeline |
| Equillium |
| Cytek Biosciences |
Equillium and Cytek Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Equillium and Cytek Biosciences
The main advantage of trading using opposite Equillium and Cytek Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Equillium position performs unexpectedly, Cytek Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cytek Biosciences will offset losses from the drop in Cytek Biosciences' long position.| Equillium vs. Lyra Therapeutics | Equillium vs. Hookipa Pharma | Equillium vs. Jasper Therapeutics | Equillium vs. Cingulate Warrants |
| Cytek Biosciences vs. Orthopediatrics Corp | Cytek Biosciences vs. Electromed | Cytek Biosciences vs. Pulmonx Corp | Cytek Biosciences vs. Rxsight |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |